20% Human Albumin Solution Infusions Seem to Improve Immune Function in Patients With Acute Decompensation and Acute-on-Chronic Liver Failure by Reversing the Immune Suppressive Effect of Prostaglandin E2 With Effect Maintained to at Least Day 10 of Treatment. The gene discussed is ALB; the disease is acute-on-chronic liver failure.